Clinical Trials on Intrauterine Device Expulsion in South Africa
Total 21 results
-
Medical University of South CarolinaAmerican Association of Orthodontics FoundationRecruiting
-
University of JohannesburgCompletedHypoactive Sexual Desire DisorderSouth Africa
-
Biotronik, Inc.CompletedPostoperative Complications | Device Replacement | Device Upgrade | Elective Replacement (ERI) | Device AdvisoryUnited States
-
The University of QueenslandQueensland Children's Hospital; Griffith University; Royal Brisbane and Women... and other collaboratorsRecruitingWound Infection | Catheter Infection | Catheter-Related Infections | Wound | Vascular Access Complication | Catheter Complications | Device Related Infection | Wound of Skin | Catheter Related Complication | Device Related Sepsis | Occlusive Dressings | Device Site ReactionsAustralia, France
-
Royal North Shore HospitalCompletedCancer | Palliative Care | Patient Reported Outcome Measures | Caregiver | Digital Health | Wearable Electronic DevicesAustralia
-
Rejoni Inc.RecruitingIntrauterine AdhesionUnited States
-
C. R. BardCompletedStenosis of Vascular Prosthetic Devices, Implants and GraftsUnited States
-
Mitja KosComunity pharmacy Celjske lekarne; Comunity pharmacy Gorenjske lekarne; Comunity... and other collaboratorsCompletedAdherence, Medication | Medicines Use Review Service | Multiple MedicationSlovenia
-
University of South CarolinaCompletedPre-Eclampsia | Intrauterine Growth Restriction | Hypertension in Pregnancy | Pre-TermUnited States
-
EndoCeutics Inc.AMAG Pharmaceuticals, Inc.WithdrawnHypoactive Sexual Desire Disorder (HSDD)United States
-
Warner ChilcottCompletedHypoactive Sexual Desire DisorderAustralia, Botswana, Canada, Germany, United Kingdom
-
Emotional Brain NY Inc.Completed
-
BioSante PharmaceuticalsCompletedHypoactive Sexual Desire DisorderUnited States, Canada
-
Palatin Technologies, IncCompletedHypoactive Sexual Desire DisorderUnited States, Canada
-
BioSante PharmaceuticalsCompletedHypoactive Sexual Desire DisorderUnited States, Canada
-
Warner ChilcottCompletedEndometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal WomenHypoactive Sexual Desire DisorderUnited States
-
BioSante PharmaceuticalsCompletedHypoactive Sexual Desire DisorderUnited States, Canada
-
EndoCeutics Inc.CompletedHypoactive Sexual Desire DisorderUnited States, Canada
-
Palatin Technologies, IncAMAG Pharmaceuticals, Inc.CompletedHypoactive Sexual Desire DisorderUnited States, Canada
-
Palatin Technologies, IncCompletedHypoactive Sexual Desire Disorder | Female Sexual Arousal DisorderUnited States, Canada
-
BioSante PharmaceuticalsCompletedHypoactive Sexual Desire DisorderUnited States, Canada